14,15-epoxy-5,8,11-eicosatrienoic acid has been researched along with Lung Injury, Acute in 1 studies
14,15-epoxy-5,8,11-eicosatrienoic acid: RN given refers to cpd without isomeric designation
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, Y | 1 |
| Liu, T | 1 |
| Duan, JX | 1 |
| Li, P | 1 |
| Sun, GY | 1 |
| Liu, YP | 1 |
| Zhang, J | 1 |
| Dong, L | 1 |
| Lee, KSS | 1 |
| Hammock, BD | 1 |
| Jiang, JX | 1 |
| Guan, CX | 1 |
1 other study available for 14,15-epoxy-5,8,11-eicosatrienoic acid and Lung Injury, Acute
| Article | Year |
|---|---|
Soluble Epoxide Hydrolase Inhibitor Attenuates Lipopolysaccharide-Induced Acute Lung Injury and Improves Survival in Mice.
Topics: 8,11,14-Eicosatrienoic Acid; Acute Lung Injury; Animals; Anti-Inflammatory Agents; Epoxide Hydrolase | 2017 |